Dipyridamole decreases dialysis risk and improves survival in patients with pre-dialysis advanced chronic kidney disease

INTRODUCTION: Dipyridamole decreases proteinuria and improves renal function progression in patients with glomerular disease through its inhibition of platelet activation and enhanced nitric oxide expression. Few studies have evaluated the effects of dipyridamole on renal outcome or survival in CKD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Ko-Lin, Hung, Szu-Chun, Tseng, Wei-Cheng, Liu, Jia-Sin, Lin, Ming-Huang, Hsu, Chih-Cheng, Tarng, Der-Cherng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797055/
https://www.ncbi.nlm.nih.gov/pubmed/29435184
http://dx.doi.org/10.18632/oncotarget.19850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797055/
https://www.ncbi.nlm.nih.gov/pubmed/29435184
http://dx.doi.org/10.18632/oncotarget.19850

Ejemplares similares